Study Type Gender, N Age1 Body weight1 (Kg) Height1 (cm) BMI1 (Kg/m2) Tobacco User2
Mean± SD Range Mean± SD Range Mean± SD Range Mean± SD Range Yes/No
Fasting 
(N=36)
Male, 18 26.78 ± 5.17 38-20 58.41 ± 7.83 73.00-46.50 168.45 ± 6.06 179.00-159.00 20.57 ± 2.47 24.94-18.10 No, 15 (83.33%)
Yes, 3 (16.67%)
Female, 18 34.09 ± 6.21 42-22 51.84 ± 5.73 61.40-43.80 152.16 ± 6.69 165.40-142.00 22.36 ± 1.30 24.81-19.74 No, 16 (88.89%)
Yes, 2 (11.11%)
Non-fasting (N=36) Male, 18 29.94 ± 7.57 44-20 54.51 ± 8.43 75.00-45.00 164.66 ± 6.35 179.20-157.00 20.01 ± 1.91 23.94-18.25 No, 17 (94.44%)
Yes, 1 (5.56%)
Female, 18 31.44 ± 5.54 42-22 49.80 ± 4.50 58.00-41.10 152.92 ± 6.09 165.00-143.00 21.30 ± 1.49 23.24-18.27 No, 18 (100.00%) Yes, 0 (0.00%)
SD: Standard Deviation; N= Number of Subjects
1Determined at Screening
2Defined as current tobacco user (consuming tobacco ≤ 2-4 packets per day since 30 days of screening)
Table 1: Demographic profiles of subjects participated into acyclovir 800mg IR tablet under fasting and non-fasting study.
Goto home»